$84.65
0.560.67%
Last update: 9:30 AM
15 minutes delayed
Sector
Healthcare
Region
US
AUM
278.10M
Fund Score
Invesco Pharmaceuticals ETF (ARCA:PJP) Quotes, Forecast and News Summary
Invesco Pharmaceuticals ETF (ARCA: PJP) stock price, news, charts, stock research, profile.
| Open | $84.65 |
| High | $84.65 |
| 52 Wk High | 85.47 |
| AUM | 278.10M |
| Dividend | $0.77 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | 467 |
| Market Cap | $131.38B |
| Mgmt Fee | 0.5% |
| P/E Ratio | 23.14 |
| Prev. Close | $84.09 |
| Low | $84.65 |
| 52 Wk Low | 67.75 |
| Shares Out | 3.42M |
| Yield | 0.92% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 7.24K |
| Beta | 0.58 |
| Avg. Expense Ratio | NA% |
| P/B Ratio | 3.07 |
Recent News
FAQ
How do I buy Invesco Pharmaceuticals ETF (PJP) stock?
You can purchase shares of Invesco Pharmaceuticals ETF (ARCA:PJP) through any online brokerage.
Who are Invesco Pharmaceuticals ETF (PJP) competitors?
There are no as such competitors for Invesco Pharmaceuticals ETF.
What is the target price for Invesco Pharmaceuticals ETF (PJP) stock?
There is no analysis for Invesco Pharmaceuticals ETF.
What is the forecast for Invesco Pharmaceuticals ETF (PJP) stock?
There is no analysis for Invesco Pharmaceuticals ETF to provide a consensus price target.
Current stock price for Invesco Pharmaceuticals ETF (PJP)?
The stock price for Invesco Pharmaceuticals ETF (ARCA: PJP) is $84.65 last updated Today at July 22, 2024 at 9:30 AM EDT.
Does Invesco Pharmaceuticals ETF (PJP) pay a dividend?
A quarterly cash dividend of 0.16 per share of Class A Common Stock. The quarterly cash dividend was payable on September 28, 2018 to stockholders of record on September 24, 2018.
When is Invesco Pharmaceuticals ETF (ARCA:PJP) reporting earnings?
Invesco Pharmaceuticals ETF does not have any upcoming earnings scheduled.
Is Invesco Pharmaceuticals ETF (PJP) going to split?
There is no upcoming split for Invesco Pharmaceuticals ETF.
ETF Details
| Sector | Healthcare |
| Category | High Performer-High Growth |
| Investment Style | Large Cap Value |
| Fund Inception | Jun 23, 2005 |
| Managers | Pratik Doshi Tony Seisser Michael Jeanette Peter Hubbard |
| Definition | A Equity Fund portfolio full of stocks with both strong financial performance and superior growth potential |
Investment Policy
The Fund generally will invest at least 90% of its total assets in securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC (ICE Data or the Index Provider) compiles and maintains the Underlying Index, which is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.